Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma by Hultcrantz, Malin, Hassoun, Hani, Korde, Neha, MacLachlan, Kylee, Mailankody, Sham, Patel, Dhwani, Shah, Urvi A., Tan, Carlyn Rose, Chung, David J., Lahoud, Oscar B., Landau, Heather J., Scordo, Michael, Shah, Gunjan L., Giralt, Sergio A., Pianko, Matthew J., Burge, Miranda, Barnett, Kelly, Salcedo, Meghan, Caple, Julia, Tran, Linh, Blaslov, Jenna, Shekarkhand, Tala, Hamid, Selena, Nemirovsky, David, Derkach, Andriy, Arisa, Oluwatobi, Peer, Cody J., Figg, William D., Usmani, Saad Z., Landgren, Ola, Lesokhin, Alexander M.

Get full text

Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, de... by Piedra, Katrina, Peterson, Tim, Tan, Carlyn, Orozco, Jennifer, Hultcrantz, Malin, Hassoun, Hani, Mailankody, Sham, Lesokhin, Alexander, Shah, Urvi, Lu, Sydney, Patel, Dhwani, Derkach, Andriy, Wilkins, Cy R., Korde, Neha

Get full text

Evaluation of the Safety and Efficacy of Denosumab in Patients with Multiple Myeloma and Severe Renal Impairment; Results from an IMWG Bone Subcommittee Study by Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Kyriakou, Charalampia, Tan, Carlyn Rose, Abildgaard, Niels, Delforge, Michel, Fantl, Dorotea Beatriz Eugenia, Seehaus, Cristian M, Carneiro, Emilie, João, Cristina, Usmani, Saad Z.

Get full text

Outcomes of Frailty Subgroups Treated with Teclistamab in the Real-World: An International Myeloma Foundation Study Database Analysis by Mian, Hira, Tan, Carlyn Rose, Asoori, Sireesha, Popat, Rakesh, Abdallah, Nadine, Chhabra, Saurabh, Parrondo, Ricardo D., Pond, Gregory R, Martin, Thomas, Durie, Brian G.M., Lin, Yi

Get full text

Targeting BCMA in Multiple Myeloma by Tan, Carlyn Rose, Shah, Urvi A.

Get full text

Real-World Patient Profile and Step-up Dosing Process of Early Initiators of Teclistamab for Multiple Myeloma in US Hospitals - an Updated Analysis Using Premier Healthcare Databas... by Tan, Carlyn Rose, Kim, Nina, Chinaeke, Eric, Hester, Laura, Fowler, Jessica, Gifkins, Dina, Lin, Dee, Walker, Sian, Fu, Alex Z., Wu, Bingcao

Get full text

P-282 Evaluation of the Safety and Efficacy of Denosumab in Patients With Multiple Myeloma and Severe Renal Impairment by Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Kyriakou, Charalampia, Tan, Carlyn, Abildgaard, Niels, Delforge, Michel, Fantl, Dorotea, Usmani, Saad

Get full text

A Multicenter, Open-Label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105 by Tan, Carlyn Rose, Barta, Stefan K., Lensing, Shelly Y., Noy, Ariela

Get full text

Immune-MRD Status Informs Tumor-MRD Outcome Prognostication in Multiple Myeloma Patients on Lenalidomide Maintenance by Firestone, Ross S, Simhal, Anish Kumar, McAvoy, Devin, Jurgens, Eric M, Garcés, Juan-José, Nemirovsky, David, Derkach, Andriy, Maclachlan, Kylee H, Hultcrantz, Malin, Mailankody, Sham, Shah, Urvi A., Tan, Carlyn Rose, Korde, Neha, Hassoun, Hani, Rajeeve, Sridevi, Hashmi, Hamza, Landau, Heather J., Scordo, Michael, Shah, Gunjan L., Giralt, Sergio, Diamond, Benjamin, Maura, Francesco, Hosszu, Kinga K., Chung, David J., Landgren, Ola, Usmani, Saad Z., Lesokhin, Alexander M.

Get full text

Long-Term Follow-up of Real-World Teclistamab Therapy for Relapsed/Refractory Multiple Myeloma from the IMWG Immunotherapy Working Group Committee by Tan, Carlyn Rose, Asoori, Sireesha, Nemirovsky, David, Derkach, Andriy, Brunaldi, Larissa, Popat, Rakesh, Lau, Chris, Kastritis, Efstathios, Martínez-Lopez, Joaquín, Bansal, Radhika, De Menezes Silva Corraes, Andre, Chhabra, Saurabh, Parrondo, Ricardo D., Ailawadhi, Sikander, Fotiou, Despina, Dimopoulos, Meletios, Yong, Kwee, Mactier, Catriona, Corona, Magdalena, Sáez Marín, Adolfo Jesús, Mian, Hira, Usmani, Saad Z., Durie, Brian G.M., Martin, Thomas G, Lin, Yi

Get full text

Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses by Hamadeh, Issam S., Shekarkhand, Tala, Rueda, Colin, Firestone, Ross S, Wang, Alice X, Korde, Neha, Hultcrantz, Malin, Lesokhin, Alexander M., Mailankody, Sham, Hassoun, Hani, Shah, Urvi A., Maclachlan, Kylee H, Rajeeve, Sridevi, Hashmi, Hamza, Shah, Gunjan L., Scordo, Michael, Chung, David J., Landau, Heather J., Giralt, Sergio A., Usmani, Saad Z., Tan, Carlyn Rose

Get full text

Manufacture of Anti-BCMA CAR T Cell Is Feasible after Salvage Autologous or Allogeneic Hematopoietic Stem Cell Transplantation by Shah, Gunjan L., Perica, Karlo, Nagel, Katherine, Payson, Erica, Hosszu, Kinga K., Chung, David J., Landau, Heather J., Scordo, Michael, Hultcrantz, Malin, Korde, Neha, Maclachlan, Kylee H, Shah, Urvi A., Tan, Carlyn Rose, Hashmi, Hamza, Lesokhin, Alexander M., Rajeeve, Sridevi, Usmani, Saad Z., Mailankody, Sham, Giralt, Sergio A.

Get full text

Impact of Absolute Lymphocyte Count at Pre-Apheresis and Pre-Lymphodepletion on Chimeric Antigen Receptor (CAR)-T Therapy Outcomes in Relapsed Refractory Multiple Myeloma (RRMM) by Nishimura, Noriko, Mailankody, Sham, Brown, Samantha, Devlin, Sean M., Costa, Bruno Almeida, Farzana, Tasmin, Jurgens, Eric M, Firestone, Ross S, Nath, Karthik, Chung, David J., Landau, Heather J., Scordo, Michael, Shah, Gunjan L., Shouval, Roni, Hashmi, Hamza, Hassoun, Hani, Maclachlan, Kylee H, Hultcrantz, Malin, Korde, Neha, Lesokhin, Alexander M., Shah, Urvi A., Tan, Carlyn Rose, Giralt, Sergio A., Usmani, Saad Z., Rajeeve, Sridevi

Get full text

Belantamab Mafodotin, nirogacestat and Pomalidomide for Patients with Relapsed/Refractory Multiple Myeloma by Hultcrantz, Malin, Hassoun, Hani, Tan, Carlyn Rose, Korde, Neha, Lesokhin, Alexander M., Hashmi, Hamza, Maclachlan, Kylee H, Rajeeve, Sridevi, Shah, Urvi A., Patel, Dhwani, Derkach, Andriy, Hamid, Selena, Shekarkhand, Tala, Tran, Linh, Caple, Julia, Barnett, Kelly, Sood, Tara, Jenna, Blaslov, Konsky, Amanda, Murata, Kazunori, Roshal, Mikhail, Giralt, Sergio A., Usmani, Saad Z., Mailankody, Sham

Get full text

Daratumumab Versus Lenalidomide As Maintenance Therapy in Newly Diagnosed Multiple Myeloma - Interim Efficacy Results of a Randomized Clinical Trial by Rajeeve, Sridevi, Derkach, Andriy, Devlin, Sean M., Santos, Jeannen, Przemielewska, Anna, Sood, Tara, Maclachlan, Kylee H, Hashmi, Hamza, Tan, Carlyn Rose, Korde, Neha, Hultcrantz, Malin, Dahi, Parastoo B, Lesokhin, Alexander M., Scordo, Michael, Chung, David J., Landau, Heather J., Shah, Gunjan L., Landgren, Ola, Giralt, Sergio A., Mailankody, Sham, Usmani, Saad Z., Shah, Urvi A.

Get full text

Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma by Costa, Bruno Almeida, Tan, Carlyn Rose, Shekarkhand, Tala, Firestone, Ross S, Jurgens, Eric M, Miller, Kevin, Lesokhin, Alexander M., Shah, Gunjan L., Korde, Neha, Rajeeve, Sridevi, Chung, David J., Landau, Heather J., Scordo, Michael, Hassoun, Hani, Maclachlan, Kylee H, Shah, Urvi A., Hultcrantz, Malin, Hamadeh, Issam S., Giralt, Sergio, Mailankody, Sham, Usmani, Saad Z., Hashmi, Hamza

Get full text

Impact of Daratumumab Refractoriness on Clinical Outcomes Following CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma by Rajeeve, Sridevi, Costa, Bruno Almeida, Jurgens, Eric M, Nishimura, Noriko, Farzana, Tasmin, Firestone, Ross S, Miller, Kevin, Lesokhin, Alexander M., Shah, Gunjan L., Korde, Neha, Tan, Carlyn Rose, Chung, David J., Landau, Heather J., Scordo, Michael, Hassoun, Hani, Maclachlan, Kylee H, Shah, Urvi A., Hultcrantz, Malin, Hamadeh, Issam S., Giralt, Sergio, Mailankody, Sham, Usmani, Saad Z., Hashmi, Hamza

Get full text

Frailty and Outcomes after Bispecific T-Cell Engager Therapy for Patients with Relapsed/Refractory Multiple Myeloma by Adegbite, Benjamin O, Tan, Carlyn Rose, Shekarkhand, Tala, Firestone, Ross S, Jurgens, Eric M, Miller, Kevin, Lesokhin, Alexander M., Shah, Gunjan L., Korde, Neha, Rajeeve, Sridevi, Chung, David J., Landau, Heather J., Scordo, Michael, Hassoun, Hani, Maclachlan, Kylee H, Shah, Urvi A., Hultcrantz, Malin, Hamadeh, Issam S., Giralt, Sergio, Mailankody, Sham, Usmani, Saad Z., Hashmi, Hamza

Get full text

Real-World Characteristics and Treatment Patterns of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Bortezomib, Lenalidomide, and Dexa... by Tan, Carlyn Rose, Gordan, Lucio, Dileo, Rachel, Mewawalla, Prerna, Larson, Sarah M., Davies, Faith E, Oveisi, David, Gupta-Werner, Niodita, Medhekar, Rohan, Cortoos, Annelore, Armoon, Marjohn, Rahman, Alvi, Vanden Eynde, Claire, Lafeuille, Marie-Hélène, Reitan, John, Milkovitch, Gary, Bubalo, Joseph, Forman, Adam, Sborov, Douglas W, Kaila, Shuchita, Usmani, Saad Z.

Get full text

Body Mass Index Trajectory during Triplet Induction Therapy: Clinical Implications in Newly Diagnosed Multiple Myeloma by Thirugnanasambandam, Ram Prakash, Firestone, Ross S, Derkach, Andriy, Furberg, Helena, Shekarkhand, Tala, Rueda, Colin, Maclachlan, Kylee H, Hultcrantz, Malin, Mailankody, Sham, Patel, Dhwani, Lahoud, Oscar Boutros, Landau, Heather J., Chung, David J., Shah, Gunjan L., Scordo, Michael, Hassoun, Hani, Lesokhin, Alexander M., Giralt, Sergio, Korde, Neha, Usmani, Saad Z., Tan, Carlyn Rose, Shah, Urvi A.

Get full text